Company Mymetics Corp OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Grants
99.7
%
| 1 | 99.3 % | 1 | 99.7 % | +113.44% |
Sales Other
0.3
%
| - | - | 0 | 0.3 % | - |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
European Union and United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +112.57% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 01/09/01 | |
Mario Amacker
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Staehelin
BRD | Director/Board Member | 76 | 02/07/02 |
Ulrich Burkhard
BRD | Director/Board Member | 63 | 23/12/23 |
Marcel B. Rüegg
BRD | Director/Board Member | - | 16/23/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 151,879 | 73,993 ( 48.72 %) | 0 | 48.72 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+8.29% | 114B | |
+10.21% | 104B | |
-11.90% | 22.41B | |
+0.64% | 22.28B | |
-5.52% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- MYMX Stock
- Stock
- Company Mymetics Corp